Public Board of Directors papers 29.09.22

Responsible Executive Director - Chief Nurse Responsible Assurance Committee – Quality/Audit/Workforce depending on risk Financial Performance Financial performance remains strong. The year-to-date position at Month 5 is a £57k surplus compared to a breakeven plan. The in-month position for month 5 is a deficit of £48k against a breakeven plan. This is in line with the annual 2022/23 revenue plan re-submitted at the end of June. This plan includes additional revenue income provided to support inflationary pressures, particularly rising energy prices, and enabled a plan to break-even overall. As shown in the table there are no significant variances from the planned financial performance against key measures.

Measure of Financial Performance

Red / Amber / Green rating

Revenue: Trust Control Total compared to breakeven plan

£57k

Capital: Capital expenditure against plan CIP achieved (recurrent) against target CIP achieved (non-recurrent) against target Debtor days compared to 15-day target

6.8% above plan £3.2m of £7.3m target £4.5m of £4.5m target

8 days

Cash balance £173,646k Financial details are provided in the Integrated Performance, Quality and Finance Report Responsible Executive Director – Finance Director Responsible Assurance Committee – Audit Operational Performance Overall performance remains strong apart from the 62-day referral to treatment standard. Following recent improvements, the August 62-day position fell to 71.3% compliance (subject to validation). Case reviews show no consistent pattern although of the 34 patients waiting longer than 62 days from referral to treatment in August, 31 were referred to The Christie more than 38 days after initial referral to a local hospital. We have continued to achieve the 31-day standard for treatment to start within 31 days of the decision to treat. Overall activity levels remain broadly in line with the 2022/23 plan with chemotherapy treatments, radiotherapy fractions and non-elective spells being above plan and no other significant variances. Of the 11 operations cancelled on the day for non-clinical reasons (mainly availability of critical care facilities) 10 have been rebooked within the 28-day target period. Performance details are in the Integrated Performance, Quality and Finance Report Responsible Executive Director – Chief Operating Officer Responsible Assurance Committee – Quality Assurance Quality of Care The reported metrics confirm that the quality of care at The Christie continues to be outstanding despite the pressures of recent years. Nurse staffing levels have remained at levels which ensure safe care for patients. Our approach is to maintain a 1:6 nurse to patient ratio. This has, on occasion, been extended to 1:8. However, this remains in line with recommended national staffing ratios. At these times there have been no reported patient safety incidents.

27